[Breast cancers associated with pregnancy. About two cases].
The association between breast cancer and pregnancy is a rare but not exceptional. The authors reports two cases of patients aged 29 and 30 years respectively. Both patients had single pregnancis. The first patient, third delivery, had a gestational age of 30 weeks of amenorrhea and a stadify T 3NIM0. The second patent was second delivery and had during her first prenatal consultation at 38 weeks of amenorrhea a developing but not extending statify T4. Cytology suggest the diagnosis whicle was confirmed by histology in both cases. Treatment consisted in an immediate Pathey for the first patient who underwent a cesarean section at 36 weeks of gestation giving birth to a newborn without distinctive features. She died after the second course of chemotherapy type FAC. The second patient had an induced labour and gave birth to a newborn without distinctive features. Chemotherapy was started after delivery but the patient died after the first course which did not improve her condition. Late diagnosis and poor prognosis are common in literature. This is confirmed by our study in which we also stress the severity of the disease and the problems related to treatment.
Ndioubnane
Mokhtar D
MD
Hopital Militaire De Nouakchott, Mauritanie.
Mahmoud
Ghoulam O
GO
Bal
Aïssata
A
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D009367:Neoplasm Staging; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy* / Q000601:surgery*; D011379:Prognosis
D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil